HC Surgical Specialists Limited (1B1)의 가격은 얼마입니까?

HC Surgical Specialists Limited (1B1)의 가격은 $0.27300242입니다.

HC Surgical Specialists Limited (1B1)의 시가 총액은 무엇입니까?

HC Surgical Specialists Limited (1B1)의 시가 총액은 $41.87M입니다.

HC Surgical Specialists Limited (1B1) 수익

HC Surgical Specialists Limited, an investment holding company, primarily delivers a diverse spectrum of medical services across Singapore. Through its network of clinics, the company specializes in endoscopic procedures, such as gastroscopies and colonoscopies, in addition to providing general surgical services with a notable focus on colorectal issues. Their expertise further extends to treating a variety of conditions, including haemorrhoids, anal fissures, hernias, anal abscesses, cholecystitis, anal fistulas, appendicitis, colorectal and gastric cancers, lipomas, and cysts, utilizing advanced techniques like vein laser vascular therapy and laparoscopy. Moreover, the company offers extensive orthopedic services. These address concerns such as joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, tenosynovitis, tunnel syndrome, and various wounds or lumps. Surgical interventions include joint replacements, arthroscopic procedures, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, and fracture management, supported by orthobiologic injections. Beyond clinical care, the company provides comprehensive home care services, encompassing medical, nursing, physiotherapy, speech, occupational therapy, and ambulance support. Their community health initiatives include health screenings, management of acute and chronic conditions, pre-employment check-ups, and participation in public health schemes such as the 'swab and send home' program, the community health assist scheme, and COVID-19 testing. To support accurate diagnosis, a full array of diagnostic tests is available, including blood work, X-rays, ultrasounds, CT scans, and MRIs. The company was founded in Singapore in 2015, where it continues to be headquartered.

연도	수익	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

수익

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	수익	수익 차이	국가
Thermo Fisher Scientific Inc. TMO.US	$7.61B	-	US
Danaher Corporation DHR.US	$4.76B	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$-252.70M	-	US
Agilent Technologies, Inc. A.US	$1.58B	-	US

회사

수익

수익 차이

국가